Company Filing History:
Years Active: 2000
Title: The Innovative Contributions of Herbert M. Anderson
Introduction
Herbert M. Anderson is a notable inventor based in Woodridge, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-HIV agents. His work has the potential to impact the treatment of HIV, showcasing the importance of innovation in medical research.
Latest Patents
Herbert M. Anderson holds a patent for a scalable method for the isolation of anti-HIV agents from tropical plants. This method efficiently isolates costatolide, an HIV-1-specific nonnucleoside reverse transcriptase inhibitor (NNRTI), from the latex of Calophyllum plants. The process yields an overall 10.6% of costatolide with a purity of 96%. The method involves repetitive recrystallization of the latex after removing oily material with hexane. Additionally, another HIV-1 NNRTI, soulattrolide, was also isolated and characterized. Both compounds have demonstrated in vitro anti-HIV activities, indicating their potential for further development.
Career Highlights
Herbert M. Anderson is associated with Sarawak Medichem Pharmaceuticals, Inc., where he continues to contribute to pharmaceutical innovations. His work emphasizes the importance of natural sources in developing effective treatments for diseases like HIV.
Collaborations
He has collaborated with notable colleagues, including Yuh-Meei Lin and Tuah R. Jenta, to advance research in this critical area of health.
Conclusion
Herbert M. Anderson's innovative work in isolating anti-HIV agents highlights the significance of research in combating viral infections. His contributions are paving the way for new treatments and improving the lives of those affected by HIV.